Camp RL[au] - Search Results

Year	Number of Results
1975	1
1991	2
1993	2
1995	1
1996	1
1999	1
2000	4
2001	3
2002	3
2003	6
2004	8
2005	10
2006	12
2007	12
2008	9
2009	13
2010	7
2011	5
2012	4
2013	3
2014	3
2015	2
2017	1
2018	1
2021	0

1

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Camp RL, Dolled-Filhart M, Rimm DL. Camp RL, et al. Clin Cancer Res. 2004 Nov 1;10(21):7252-9. doi: 10.1158/1078-0432.CCR-04-0713. Clin Cancer Res. 2004. PMID: 15534099 Free article.

2

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Camp RL, Neumeister V, Rimm DL. Camp RL, et al. J Clin Oncol. 2008 Dec 1;26(34):5630-7. doi: 10.1200/JCO.2008.17.3567. Epub 2008 Oct 20. J Clin Oncol. 2008. PMID: 18936473 Review.

3

Amplification of tissue by construction of tissue microarrays.

Rimm DL, Camp RL, Charette LA, Olsen DA, Provost E. Rimm DL, et al. Among authors: camp rl. Exp Mol Pathol. 2001 Jun;70(3):255-64. doi: 10.1006/exmp.2001.2363. Exp Mol Pathol. 2001. PMID: 11418004 Review.

4

Automated analysis of tissue microarrays.

Dolled-Filhart M, Gustavson M, Camp RL, Rimm DL, Tonkinson JL, Christiansen J. Dolled-Filhart M, et al. Among authors: camp rl. Methods Mol Biol. 2010;664:151-62. doi: 10.1007/978-1-60761-806-5_15. Methods Mol Biol. 2010. PMID: 20690061

5

Bimodal population or pathologist artifact?

Rimm DL, Giltnane JM, Moeder C, Harigopal M, Chung GG, Camp RL, Burtness B. Rimm DL, et al. Among authors: camp rl. J Clin Oncol. 2007 Jun 10;25(17):2487-8. doi: 10.1200/JCO.2006.07.7537. J Clin Oncol. 2007. PMID: 17557963 No abstract available.

6

CD70 expression patterns in renal cell carcinoma.

Jilaveanu LB, Sznol J, Aziz SA, Duchen D, Kluger HM, Camp RL. Jilaveanu LB, et al. Among authors: camp rl. Hum Pathol. 2012 Sep;43(9):1394-9. doi: 10.1016/j.humpath.2011.10.014. Epub 2012 Mar 7. Hum Pathol. 2012. PMID: 22401771 Free PMC article.

7

Antimicrobial polymers.

Ackart WB, Camp RL, Wheelwright WL, Byck JS. Ackart WB, et al. Among authors: camp rl. J Biomed Mater Res. 1975 Jan;9(1):55-68. doi: 10.1002/jbm.820090106. J Biomed Mater Res. 1975. PMID: 809445

8

NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.

Giesen E, Jilaveanu LB, Parisi F, Kluger Y, Camp RL, Kluger HM. Giesen E, et al. Among authors: camp rl. Oncotarget. 2014 Jul 30;5(14):5209-17. doi: 10.18632/oncotarget.2101. Oncotarget. 2014. PMID: 24970819 Free PMC article.

9

Vascularity of primary and metastatic renal cell carcinoma specimens.

Aziz SA, Sznol J, Adeniran A, Colberg JW, Camp RL, Kluger HM. Aziz SA, et al. Among authors: camp rl. J Transl Med. 2013 Jan 14;11:15. doi: 10.1186/1479-5876-11-15. J Transl Med. 2013. PMID: 23316728 Free PMC article.

10

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.

Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, Boeke M, Neumeister V, Camp RL, Adeniran A, Pins M, Manola J, DiPaola RS, Haas NB, Kluger HM. Jilaveanu LB, et al. Among authors: camp rl. Clin Cancer Res. 2018 Jan 1;24(1):217-223. doi: 10.1158/1078-0432.CCR-17-1555. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066509 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results